Indianapolis, IN, United States of America

Cynthia Darshini Jesudason

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 1998-2022

Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Cynthia Darshini Jesudason: Innovating in Diabetes Treatment

Introduction: Cynthia Darshini Jesudason, a talented inventor based in Indianapolis, IN, has made significant contributions to the field of pharmaceuticals with 27 patents under her name.

Latest Patents:

1. Triazolo Derivatives as PDE1 Inhibitors for the Treatment of Diabetes: Cynthia's invention provides a compound for use as a human PDE inhibitor, aimed at treating diabetes.

2. Azetidinyloxyphenylpyrrolidine Compounds: This invention offers methods of using compounds to treat overactive bladder, showing her diverse expertise in pharmaceuticals.

Career Highlights:

Cynthia Darshini Jesudason is associated with Eli Lilly and Company, a renowned pharmaceutical firm. Her innovative spirit and scientific prowess have led to pioneering inventions in the healthcare industry.

Collaborations:

Cynthia has collaborated with esteemed professionals at Eli Lilly and Company, including Freddie Craig Stevens and Don Richard Finley. Such collaborations have fueled her inventive journey and allowed for groundbreaking discoveries in pharmaceuticals.

Conclusion:

In conclusion, Cynthia Darshini Jesudason's remarkable work in inventing compounds for diabetes treatment and addressing overactive bladder showcases her dedication to advancing healthcare solutions. With a strong background in pharmaceuticals and ongoing collaborations, Cynthia continues to make a significant impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…